Research links anti-seizure drug to birth defects

07/22/2008 | Bloomberg

The rate of children born with cleft palates or cleft lips was 11 times higher among female patients taking Topamax, Johnson & Johnson's anti-seizure drug, alone or with other medication, according to a study of 203 pregnancies. For boys, a genital defect was 14 times higher than normal. The U.K. researchers said the findings are similar to those from studies of other epilepsy treatments, but a bigger study is necessary to get more conclusive results.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ